This paper discusses shifts in development assistance for health (DAH) since 1990, analyses the nature of the current distribution of funding, and considers future implications. Based on Jamison et al. (1998) and Frenk and Moon (2013), we introduce an .es

A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs). The international agencies have forgotten pregnant women. Given the unacceptably high number of maternal and perinatal...

Background The global burden of diabetes is rising rapidly, yet there is little evidence on individual-level diabetes prevention activities undertaken by health systems in low-income and middle-income countries (LMICs). Here we describe the population at high risk of developing diabetes,...

Climate change poses an unprecedented challenge to population health and health systems' resilience. While earlier studies have estimated morbidity attributable to hot or cold weather across cities, we provide the first large-scale, population-wide assessment of extreme temperatures on...

Shortages, geographic imbalances, and poor performance of health workers pose major challenges for improving health service delivery in developing countries. In response, development agencies have increasingly recognized the need to invest in Human Resources for Health (HRH) to assist countries...